LAMELLAR BIOMEDICAL LIMITED
LAMELLAR BIOMEDICAL LIMITED
LAMELLAR BIOMEDICAL LIMITED
Company Registration Number:
SC312123 (Scotland)
Unaudited abridged accounts for the year ended 30 June 2021
Period of accounts
Start date: 01 July 2020
End date: 30 June 2021
LAMELLAR BIOMEDICAL LIMITED
Contents of the Financial Statements
for the Period Ended 30 June 2021
Balance sheet | |
Notes |
LAMELLAR BIOMEDICAL LIMITED
Balance sheet
As at
Notes | 2021 | 2020 | |
---|---|---|---|
| £ | £ | |
Fixed assets | |||
Tangible assets: | 3 | | |
Total fixed assets: | | | |
Current assets | |||
Debtors: | | | |
Cash at bank and in hand: | | | |
Total current assets: | | | |
Creditors: amounts falling due within one year: | ( | ( | |
Net current assets (liabilities): | ( | | |
Total assets less current liabilities: | | | |
Total net assets (liabilities): | | | |
Capital and reserves | |||
Called up share capital: | | | |
Share premium account: | | | |
Profit and loss account: | ( | ( | |
Shareholders funds: | | |
The notes form part of these financial statements
LAMELLAR BIOMEDICAL LIMITED
Balance sheet statements
The directors have chosen to not file a copy of the company’s profit & loss account.
This report was approved by the board of directors on
and signed on behalf of the board by:
Name:
Status: Director
The notes form part of these financial statements
LAMELLAR BIOMEDICAL LIMITED
Notes to the Financial Statements
for the Period Ended 30 June 2021
1. Accounting policies
LAMELLAR BIOMEDICAL LIMITED
Notes to the Financial Statements
for the Period Ended 30 June 2021
2. Employees
2021 | 2020 | |
---|---|---|
Average number of employees during the period | | |
LAMELLAR BIOMEDICAL LIMITED
Notes to the Financial Statements
for the Period Ended 30 June 2021
3. Tangible Assets
Total | |
---|---|
Cost | £ |
At 01 July 2020 | |
Additions | |
Disposals | ( |
At 30 June 2021 | |
Depreciation | |
At 01 July 2020 | |
Charge for year | |
On disposals | ( |
At 30 June 2021 | |
Net book value | |
At 30 June 2021 | |
At 30 June 2020 | |